Coronavirus vaccine could be ready in September, Oxford scientist claims

Pharmacist Michael Witte, left, gives Rebecca Sirull, right, a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren) Copyright 2020 The Associated Press. All rights reserved.

A coronavirus vaccine could be available for the general public by September, an Oxford scientist has claimed.

Email this article to a friend To send a link to this page you must be logged in.

Become a Supporter Almost four years after its creation The New European goes from strength to strength across print and online, offering a pro-European perspective on Brexit and reporting on the political response to the coronavirus outbreak, climate change and international politics. But we can only continue to grow with your support.

Have your say Send your letters for publication to The New European by emailing letters@theneweuropean.co.uk and pick up an edition each Thursday for more comment and analysis. Find your nearest stockist here or subscribe to a print or digital edition for just £13. You can also join our readers' Facebook group to keep the discussion and debate going with thousands of fellow pro-Europeans.

Sarah Gilbert, a professor of vaccinology at Oxford University, is leading a team of researchers in the development of a vaccine that would protect the world against coronavirus.

In an interview with The Times, the professor said that she and her team have already created a potential vaccine that is due to begin human trials within two weeks.

She told the paper she is “80%” confident of its success, “based on other things that we have done with this type of vaccine”.

You may also want to watch:

Most industry experts say that a vaccine could take as long as 18 months to be developed and distributed globally.

However, Professor Gilbert believes that by letting volunteers from places that have not imposed lockdown measures become infected naturally as soon as possible, will accelerate the clinical trial process.

“If one of those (places) turns out to have a high rate of virus transmission then we will get our efficacy results very quickly, so that is one strategy for reducing the time,” she said.

“Total lockdowns do make it harder. But we don’t want the herd immunity either. We want them to be susceptible and exposed for the trials purely to test the efficacy.”

In order for the vaccine to be distributed in the autumn, Professor Gilbert says the Government will need to start production before it is proven to work.

She told the paper: “We don’t want to get to later this year and discover we have a highly effective vaccine and we haven’t got any vaccine to use.”